The FDA in the U.S. on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days. This is the 1st pill specifically intended for this purpose.

The FDA in the U.S. on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days. This is the 1st pill specifically intended for this purpose.